Position in EYPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,393,349
+$147,183 QoQ
Shares Held
97,437
+0.8% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 188 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. EYPT ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,393,349 | 97,437 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,246,166 | 96,677 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,626,852 | 89,045 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,287,196 | 90,393 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $905,994 | 96,280 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $470,087 | 86,732 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $667,222 | 89,560 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $616,164 | 77,117 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $668,447 | 76,833 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,197,537 | 57,936 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,066,295 | 46,140 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $333,598 | 41,752 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $351,688 | 40,424 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $115,295 | 39,216 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $132,072 | 37,735 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $296,387 | 37,470 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $278,023 | 35,327 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $357,975 | 29,463 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $269,586 | 22,025 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $229,385 | 22,014 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $185,634 | 20,649 | Shares | Sole | 2021-08-05 | |
| 2020-03-31 | $53,755 | 52,701 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||